tirzepatide injection Weight Loss Injections Tirzepatide Weight Loss Injections |
Description
Learn how they transform health & well-being.
Dose reduction was required in 12.5% of patients, mostly owing to gastrointestinal symptoms, and discontinuation for any reason occurred in 5.5%
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Whilst all GLP-1RAs use has increased, the largest change was seen in patients using tirzepatide and semaglutide ([figure 1B][1])
Explore what we offer for mental health, men's and women's health, hair and skin, more.
Strong Shelf Appeal
The 5-year compound annual growth rate for this group of medicines was 36% compared with 2% for the traditional diabetes therapies
